LAB standard Biotools announces sale of mass cytometry business and illumina’s buyout of contingent payments to advance merger with treeline
LAB standard Biotools announces sale of mass cytometry business and illumina’s buyout of contingent payments to advance merger with treeline Biosciences Standard Biotools - to sell mass cytometry business to multiplex Bio - Mass cytometry business sale valued at up to $10M